Moody National Bank Trust Division’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Moody National Bank Trust Division’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-82,807	Closed	-$57K	–	407
2020 Q4	$57K	Hold	82,807	–	–	﹤0.01%	391
2020 Q3	$187K	Hold	82,807	–	–	0.01%	358
2020 Q2	$295K	Hold	82,807	–	–	0.01%	315
2020 Q1	$316K	Buy	+82,807	New	+$273K	0.01%	287

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Moody National Bank Trust Division's BMY.RT Position: Q1 2021 in Review

Moody National Bank Trust Division sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 82,807 shares — an estimated $57K sold.

Moody National Bank Trust Division first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $316K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Moody National Bank Trust Division reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Moody National Bank Trust Division sold 82,807 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $57K.
Moody National Bank Trust Division first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
Moody National Bank Trust Division's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $316K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Moody National Bank Trust Division's 13F filing for Q1 2021, filed 14 Apr 2021.